![Frontiers | Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer | Oncology Frontiers | Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer | Oncology](https://www.frontiersin.org/files/Articles/703802/fonc-11-703802-HTML/image_m/fonc-11-703802-g001.jpg)
Frontiers | Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer | Oncology
![Motorleverandør snød DSB, blev dømt og ville tvinge DSB til at opgive erstatning. Nu har DSB indgået forlig og betalt 50 mio. kroner | MobilityTech (PRO) Motorleverandør snød DSB, blev dømt og ville tvinge DSB til at opgive erstatning. Nu har DSB indgået forlig og betalt 50 mio. kroner | MobilityTech (PRO)](https://pro.ing.dk/sites/mi/files/styles/automatic_crop_16_9/public/2021-01/26696.jpg?itok=UuKZmuVS)
Motorleverandør snød DSB, blev dømt og ville tvinge DSB til at opgive erstatning. Nu har DSB indgået forlig og betalt 50 mio. kroner | MobilityTech (PRO)
![Cancers | Free Full-Text | Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors | HTML Cancers | Free Full-Text | Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors | HTML](https://www.mdpi.com/cancers/cancers-12-01502/article_deploy/html/images/cancers-12-01502-g001-550.jpg)